{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"description":"Binary endpoint: met if subject received chemotherapy in the last 14 days of life","groups":[{"description":"Patients with aggressive hematologic malignancies who are hospice eligible, not pursuing further cancer directed therapy, and whose primary hematologist is planning to initiate a conversation regarding transition to hospice will be eligible for enrollment.\n\nTransfusion support: Patients will be offered symptom-driven transfusion support in addition to standard hospice care","id":"OG000","title":"Intervention Arm"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Last 14 days of life","title":"Receipt of Chemotherapy in the Last 14 Days of Life","type":"SECONDARY","unitOfMeasure":"Participants"}